Cutter Capital Management, LP Agios Pharmaceuticals, Inc. Transaction History
Cutter Capital Management, LP
- $244 Billion
- Q4 2024
A detailed history of Cutter Capital Management, LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutter Capital Management, LP holds 301,623 shares of AGIO stock, worth $9.44 Million. This represents 4.06% of its overall portfolio holdings.
Number of Shares
301,623
Previous 186,623
61.62%
Holding current value
$9.44 Million
Previous $8.29 Billion
19.53%
% of portfolio
4.06%
Previous 2.45%
Shares
3 transactions
Others Institutions Holding AGIO
# of Institutions
244Shares Held
59.9MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$178 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$176 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$152 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$110 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$75.9 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.72B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...